Internal Medicine Alert – March 30, 2006
March 30, 2006
View Issues
-
In Search of the Healthy Diet
Three diets were studied replacing saturated fats with 1) a carbohydrate-rich diet, 2) a protein-rich diet, and 3) a diet rich in unsaturated fat (predominately monounsaturated fat). -
PDE5 Inhibition: New Drug for Raynaud Disease?
Add vardenafil to the list of phosphodiesterase type 5 inhibitors with promise in the treatment of Raynaud disease. -
Troponin vs CKMB in ACS
Among patients with NSTE ACS, an elevated troponin level identifies patients at increased acute risk regardless of CK-MB status, but an isolated CK-MB+ status has limited prognostic value. -
A Normal Temperature May Not Be What We Were Taught
Mean oral temperatures decline with age, ranging from 97.3°F at 6 am to 97.8°F at 10 pm in persons older than 65 years. The majority of both nursing home and community elderly have normal mean temperatures below 98.6°F. -
An Upgraded Blood Test That Identifies Tuberculous Infection
The CDC recommends that QuantiFERON®-TB Gold (QFT-G) may be used in all circumstances in which the TST is currently used, including contact investigations, evaluation of recent immigrants, and sequential-testing surveillance programs for infection control (eg, those for health-care workers). -
Insulin Human Inhalation Powder (Exubera®)
The fda has approved the first non-injectable insulin for the treatment of type 1 and type 2 diabetes called Exubera®. -
Clinical Briefs By Louis Kuritzky, MD
Although cigarette smoking is the primary risk factor for lung cancer (LCA), with similar amounts of smoking exposure some groups demonstrate greater incidence of LCA than others.